Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 499.41M P/E - EPS this Y -4.40% Ern Qtrly Grth -
Income -57.86M Forward P/E -8.32 EPS next Y 3.00% 50D Avg Chg 3.00%
Sales 76.58M PEG -0.25 EPS past 5Y - 200D Avg Chg 25.00%
Dividend N/A Price/Book 3.74 EPS next 5Y 20.10% 52W High Chg -46.00%
Recommedations 1.80 Quick Ratio 7.75 Shares Outstanding 39.15M 52W Low Chg 225.00%
Insider Own 5.21% ROA -20.25% Shares Float 37.46M Beta 0.63
Inst Own 94.11% ROE -49.22% Shares Shorted/Prior 1.80M/1.45M Price 13.23
Gross Margin 74.19% Profit Margin -75.56% Avg. Volume 239,400 Target Price 14.00
Oper. Margin -75.17% Earnings Date Oct 28 Volume 203,025 Change -4.20%
About Pulmonx Corporation

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Pulmonx Corporation News
11/21/24 Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect?
11/20/24 Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference
11/19/24 Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers
11/07/24 Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
11/05/24 Pulmonx to Present at the Stifel 2024 Healthcare Conference
11/05/24 Wall Street Analysts Predict an 89.61% Upside in Pulmonx (LUNG): Here's What You Should Know
11/02/24 Here's What Analysts Are Forecasting For Pulmonx Corporation (NASDAQ:LUNG) After Its Third-Quarter Results
11/01/24 Pulmonx Third Quarter 2024 Earnings: EPS Beats Expectations
10/31/24 Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...
10/30/24 Pulmonx Corporation (LUNG) Reports Q3 Loss, Misses Revenue Estimates
10/30/24 Pulmonx Reports Third Quarter 2024 Financial Results
10/16/24 Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024
09/09/24 Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024
08/29/24 Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference
08/22/24 Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference
08/02/24 Analysts Are Updating Their Pulmonx Corporation (NASDAQ:LUNG) Estimates After Its Second-Quarter Results
07/31/24 Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates
07/31/24 Pulmonx Reports Second Quarter 2024 Financial Results
07/29/24 Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference
07/10/24 Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024
LUNG Chatroom

User Image NVDAMillionaire Posted - 16 hours ago

$LUNG Pulmonx Corporation (LUNG): A Leader in Minimally Invasive Lung Disease Treatments https://beyondspx.com/article/pulmonx-corporation-lung-a-leader-in-minimally-invasive-lung-disease-treatments

User Image Gettingtillywithit Posted - 5 days ago

$LUNG something going on with long big volume for 20 minutes short returned a bunch of stock. It looks like it’s about to do something crazy.

User Image Gettingtillywithit Posted - 1 week ago

$LUNG returning shares from shorts highest available in months

User Image Gettingtillywithit Posted - 1 week ago

$LUNG stock could easily be a takeover in CITI could easily be in on it

User Image Gettingtillywithit Posted - 1 week ago

$LUNG 12,000 block up

User Image anachartanalyst Posted - 1 week ago

$LUNG https://anachart.com/wp-content/uploads/ana_temp/1733922099_soc-img.jpg

User Image Gettingtillywithit Posted - 2 weeks ago

$LUNG is there anyone here on this board that listened to that conference call yesterday? I thought it was amazing especially where they said they don’t need any money and they’re not gonna do a raise and the CEO said the stock was grossly undervalued today’s action is just bizarre.

User Image Gettingtillywithit Posted - 2 weeks ago

$LUNG CEO AT PIPER SAYS DOES NOT GET SEE WHY STOCK NOT HIGHER HE BOUGHT IN OPEN MARKET

User Image Gettingtillywithit Posted - 2 weeks ago

$LUNG the CEO said in the conference call he did not know why the stock was not trading substantially higher and he bought stock in the open market. He would know.

User Image Gettingtillywithit Posted - 2 weeks ago

$LUNG you can’t possibly get a better conference call than long just presented at Piper

User Image Gettingtillywithit Posted - 2 weeks ago

$LUNG NO CAPITAL RAISE!!

User Image Gettingtillywithit Posted - 2 weeks ago

$LUNG shorts returned decent amount hope we get FDA TYPE UPDATES

User Image Gettingtillywithit Posted - 3 weeks ago

$LUNG JUST HALT IT BEFORE PIPER CONF TOMORROW!!’

User Image Gettingtillywithit Posted - 3 weeks ago

$LUNG I am killing this so bad!!

User Image Gettingtillywithit Posted - 3 weeks ago

$LUNG HALT IT!!!

User Image Gettingtillywithit Posted - 3 weeks ago

$LUNG the American LUNG association is going to essentially start doing ads for PULMONX!!’

User Image Gettingtillywithit Posted - 3 weeks ago

$LUNG I am not saying it is, but I am saying I don’t understand why pulmonx would not be bought out

User Image Gettingtillywithit Posted - 3 weeks ago

$LUNG what was that massive open?

User Image Gettingtillywithit Posted - 1 month ago

$LUNG I have enough LUNG to consider myself in group of 95% non retail that own LUNG

User Image Gettingtillywithit Posted - 1 month ago

$LUNG GOING TO PIPER CONFERENCE!! Cannacord tomorrow!!!

User Image Gettingtillywithit Posted - 1 month ago

$LUNG we need knockout punch tomorrow at Cannacord!!

User Image SilenceD0G00d Posted - 1 month ago

$LUNG aaaaand I’m back in

User Image Gettingtillywithit Posted - 1 month ago

$LUNG that was very very professional!!!

User Image Gettingtillywithit Posted - 1 month ago

$LUNG AMERICAN LUNG ASSOC DEAL JUST ANNOUNCED WITH LUNG

User Image Gettingtillywithit Posted - 1 month ago

$LUNG guy speaks well

User Image Gettingtillywithit Posted - 1 month ago

$LUNG they start at 9:10 am !!! Could 💣 open!!!

User Image Gettingtillywithit Posted - 1 month ago

$LUNG both my stocks at Stifel Tom IOVA SND LUNG

User Image RocketThief Posted - 1 month ago

$LUNG added

User Image MrBULL22 Posted - 1 month ago

$CERO $HIMS $HSCS $BCLI $LUNG

User Image Gettingtillywithit Posted - 1 month ago

$LUNG reason stock down is POINT 72 sold all!!! now we can concentrate on earnings(great) and CEO buy in market etc. not fighting hedge

Analyst Ratings
Piper Sandler Overweight Aug 1, 24
Canaccord Genuity Buy Aug 1, 24
Wells Fargo Equal-Weight Aug 1, 24
Lake Street Buy Jun 4, 24
Canaccord Genuity Buy May 2, 24
Piper Sandler Overweight Apr 3, 24
Citigroup Buy Feb 23, 24
Wells Fargo Equal-Weight Feb 23, 24
Stifel Buy Feb 22, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Rose Geoffrey Beran CHIEF COMMERCIAL OFF.. CHIEF COMMERCIAL OFFICER Jan 22 Sell 13.13 1,184 15,546 244,233 01/24/24
French Glendon E. III PRESIDENT AND CEO PRESIDENT AND CEO Jan 18 Sell 12.77 10,000 127,700 1,141,344 01/22/24
French Glendon E. III President and CEO President and CEO Dec 21 Sell 12.42 10,000 124,200 1,151,344 12/22/23
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Nov 22 Sell 10.60 1,184 12,550 249,469 11/27/23
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Oct 23 Sell 8.35 1,184 9,886 250,653 10/25/23
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Sep 22 Sell 10.51 1,184 12,444 251,837 09/26/23
Sung Derrick Chief Financial Offi.. Chief Financial Officer Sep 01 Sell 10.01 4,219 42,232 391,041 09/06/23
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Sep 01 Sell 10.01 2,843 28,458 253,021 09/06/23
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Aug 23 Sell 10.54 1,184 12,479 255,864 08/25/23
French Glendon E. III President and CEO President and CEO Jul 20 Sell 12.68 15,000 190,200 1,174,547 07/24/23
Sung Derrick Chief Financial Offi.. Chief Financial Officer Jun 01 Sell 11.49 4,222 48,511 395,260 06/02/23
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Jun 01 Sell 11.48 2,845 32,661 257,048 06/02/23
Lehman David Aaron General Counsel General Counsel Jun 01 Sell 11.48 3,776 43,348 157,420 06/02/23
French Glendon E. III President and CEO President and CEO Jun 01 Sell 11.48 6,533 74,999 1,199,547 06/02/23
French Glendon E. III President and CEO President and CEO Mar 01 Sell 11.03 2,895 31,932 1,032,580 03/03/23
French Glendon E. III President and CEO President and CEO Dec 01 Sell 5.93 3,631 21,532 1,034,313 12/05/22
Lehman David Aaron General Counsel General Counsel Dec 01 Sell 5.93 1,069 6,339 44,160 12/05/22
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Dec 01 Sell 5.93 1,055 6,256 181,037 12/05/22
Sung Derrick Chief Financial Offi.. Chief Financial Officer Dec 01 Sell 5.93 1,069 6,339 262,746 12/05/22
Lynch Alissa Hsu Director Director Nov 29 Buy 5.51 1,700 9,367 11,910 12/01/22
Ferrari Richard Director Director Nov 08 Buy 5.3 5,438 28,821 30,035 11/10/22
Sung Derrick Chief Financial Offi.. Chief Financial Officer Sep 01 Sell 17.87 1,082 19,335 253,815 09/06/22
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Sep 01 Sell 17.89 1,027 18,373 182,092 09/06/22
Lehman David Aaron General Counsel General Counsel Sep 01 Sell 17.89 1,082 19,357 45,229 09/06/22
French Glendon E. III President and CEO President and CEO Sep 01 Sell 17.87 2,940 52,538 1,052,944 09/06/22
French Glendon E. III President and CEO President and CEO Aug 18 Sell 20.59 50,000 1,029,500 1,055,884 08/22/22
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Jun 01 Sell 18.05 1,011 18,249 183,118 06/03/22
Sung Derrick Chief Financial Offi.. Chief Financial Officer Jun 01 Sell 18.05 1,065 19,223 254,897 06/03/22
French Glendon E. III President and CEO President and CEO Jun 01 Sell 18.05 2,523 45,540 1,104,994 06/03/22
Lehman David Aaron General Counsel General Counsel Jun 01 Sell 18.05 1,065 19,223 46,311 06/03/22
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Mar 10 Option 2.10 29,427 61,797 184,129 03/11/22
Sung Derrick Chief Financial Offi.. Chief Financial Officer Mar 01 Sell 25.91 458 11,867 224,962 03/03/22
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Mar 01 Sell 25.91 426 11,038 123,702 03/03/22
Lehman David Aaron General Counsel General Counsel Mar 01 Sell 25.91 458 11,867 16,376 03/03/22
French Glendon E. III President and CEO President and CEO Mar 01 Sell 25.91 1,132 29,330 1,062,817 03/03/22
French Glendon E. III President and CEO President and CEO Feb 17 Sell 27.05 25,000 676,250 1,063,949 02/22/22
French Glendon E. III President and CEO President and CEO Jan 20 Sell 24.91 25,000 622,750 1,088,949 01/24/22
French Glendon E. III President and CEO President and CEO Dec 16 Sell 31.33 25,000 783,250 1,113,949 12/17/21
Sung Derrick Chief Financial Offi.. Chief Financial Officer Dec 14 Sell 31.66 6,000 189,960 225,420 12/16/21
French Glendon E. III President and CEO President and CEO May 20 Option 2.2 10,000 22,000 1,259,884 12/03/21
French Glendon E. III President and CEO President and CEO May 20 Sell 41.6 25,000 1,040,000 1,234,884 12/03/21
French Glendon E. III President and CEO President and CEO Apr 15 Option 2.2 25,000 55,000 1,274,884 12/03/21
French Glendon E. III President and CEO President and CEO Apr 15 Sell 43.93 25,000 1,098,250 1,249,884 12/03/21
French Glendon E. III President and CEO President and CEO Nov 18 Sell 36.51 25,000 912,750 1,105,370 11/22/21
French Glendon E. III President and CEO President and CEO Oct 21 Sell 39.81 25,000 995,250 1,130,370 10/22/21